+





NiTime Aligners: A Potential Game-Changer for Your Practice

Get Introduced

OrthoFX has recently unveiled the NiTime Aligners, the world’s first FDA-cleared system designed for night wear or reduced daily wear time. This innovative aligner system boasts a hyper-elastic polymer construction that performs accurately with only 40% to 60% the standard wear time.

Milestone Achievements in Treatment:
➡️ Cases Completed (including FDA submission): 6,042
➡️ Unplanned Refinement Rate: 18% 
➡️ Average Treatment Time: 6-8 months vs. Industry Standard of 12-14 months
➡️ Treatments Completed on Time: Aligned with Refinement Rate*

3 Reasons Why to Try

When technology aligns with biology,
the extraordinary becomes possible.

Enhanced efficiency

NiTime aligners outperform the industry standard 22-hour wear aligners for almost all orthodontic movements, demonstrating up to 30% greater movement efficiency compared to standard industry aligners1.

Predictable Precision

Standard aligners exhibit a 14% predictability2 of tooth movement compared to the treatment plan. NiTime’s AirShell Technology demonstrates an astonishing 78% predictability, nearly eliminating the need for refinements throughout the entire treatment1.

Unmatched Performance

The exceptional predictability and performance of NiTime ensure efficient progress, motivating patients to wear it consistently for optimal results.

Trusted by thousands of dental professionals. Groundbreaking technology for a high-performance aligner system.

- Neil Warshawsky DDS, MS, PC // Get it Straight Orthodontics
"OrthoFx is the only system I've ever seen that is always in biological range."

- Dr. Terry Sellke // Orthodontic Specialists of Lake County
"By the time I had the first ten in treatment, I knew that I had found the holy grail of plastic treatment."

© Patient Prism, 2024. All Rights Reserved.


1. Data is as per the data on file and FDA clearance data. 

2. Data as per the research paper What percentage of patients switch from Invisalign to braces? A retrospective study evaluating the conversion rate, number of refinement scans, and length of treatment by Neal Kravtiz et.al.

*Neal D. Kravitz,ᵃ Bassel Dalloul,ᵇ Yara Aba Zaid,ᶜ Chandani Shah,ᵈ and Nikhilesh R. Vaidᵉ ​ South Riding, Va, Abu Dhabi, and Dubai, United Arab Emirates, and Mumbai, and Chennai, India